Skip to content
TrialScanner

NCT02483533

Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202

Phase 3TerminatedEVFMLead

Registry record

Lead sponsor
Evofem Inc.
Conditions
Central Abdominal Bulging
Primary completion
Dec 23, 2015Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02483533 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02483533: Extension Study to Evaluate... | TrialScanner